1 | epidemiological | 3,293 |
2 | preclinical | 2,405 |
3 | epidemiologic | 1,717 |
4 | neuroimaging | 592 |
5 | ethnobotanical | 475 |
6 | in-vitro | 373 |
7 | pre-clinical | 302 |
8 | ethnopharmacological | 281 |
9 | in-vivo | 208 |
10 | correlative | 137 |
11 | anthropological | 78 |
12 | ex-vivo | 72 |
13 | entomological | 57 |
14 | archaeological | 44 |
15 | nonexperimental | 40 |
16 | pharmacoepidemiological | 36 |
17 | ethnobiological | 26 |
18 | seroepidemiological | 22 |
19 | ethnozoological | 21 |
20 | ethno-botanical | 20 |
21 | autoradiographic | 17 |
22 | brain-imaging | 10 |
23 | neuro-imaging | 10 |
24 | toxicogenomic | 9 |
25 | ethno-pharmacological | 8 |
26 | phytopharmacological | 7 |
27 | preformulation | 7 |
28 | pharmacognostical | 6 |
29 | clinico-epidemiological | 5 |
30 | continuous-feed | 5 |
31 | ethnobotanic | 5 |
32 | ethnomycological | 5 |
33 | non-asian-dominant | 5 |
34 | preclinical/clinical | 5 |
35 | time-of-addition | 5 |
36 | biodemographic | 4 |
37 | flow-microscopy | 4 |
38 | hiv/hpv | 4 |
39 | hypothesis-based | 4 |
40 | patophysiological | 4 |
41 | radioligand-binding | 4 |
42 | rnaseq | 4 |
43 | sero-epidemiological | 4 |
44 | seroepidemiologic | 4 |
45 | titration-to-response | 4 |
46 | anti-aml | 3 |
47 | asian-specific | 3 |
48 | decision-analysis-based | 3 |
49 | epidemiological/clinical | 3 |
50 | ethnographical | 3 |
51 | ethnological | 3 |
52 | gst-pulldown | 3 |
53 | histocytological | 3 |
54 | isotope-labeling | 3 |
55 | mechanistical | 3 |
56 | non-pooled | 3 |
57 | non-rodent | 3 |
58 | nonindustry | 3 |
59 | pharmacal | 3 |
60 | spinal-reflex | 3 |
61 | summary-level | 3 |
62 | transcriptome-scale | 3 |
63 | aerobiological | 2 |
64 | carefully-designed | 2 |
65 | cric/h-cric | 2 |
66 | decision-modeling | 2 |
67 | eppm-based | 2 |
68 | equigen | 2 |
69 | immuno-histological | 2 |
70 | insync-icd | 2 |
71 | literature-reported | 2 |
72 | meta-profiling | 2 |
73 | microneurographic | 2 |
74 | monophagous | 2 |
75 | nanoparticle-cell | 2 |
76 | paleoparasitological | 2 |
77 | palynological | 2 |
78 | pharmacokinetic/pharmacodynamics | 2 |
79 | phenotype/genotype | 2 |
80 | postrotation | 2 |
81 | quadrat | 2 |
82 | radioecological | 2 |
83 | random-control | 2 |
84 | rct-level | 2 |
85 | rt-tmz-10.00 | 2 |
86 | thermal-conductivity | 2 |
87 | ua- | 2 |
88 | 4,884 | 1 |
89 | 41,175 | 1 |
90 | anatomo-histopathological | 1 |
91 | bencaological | 1 |
92 | best-conducted | 1 |
93 | bioptical | 1 |
94 | brec | 1 |
95 | case-series/registry | 1 |
96 | comparators.two | 1 |
97 | depression.the | 1 |
98 | designs-randomized | 1 |
99 | direct-tracking | 1 |
100 | ecological-genomic | 1 |
101 | ethnopharmacobotanical | 1 |
102 | experimental-pharmacological | 1 |
103 | functionai | 1 |
104 | genome-analysis | 1 |
105 | health.five | 1 |
106 | hrql.further | 1 |
107 | iris/enest-nd/dasision | 1 |
108 | jcpds | 1 |
109 | longest-duration | 1 |
110 | low-coverage | 1 |
111 | mechanism/efficacy | 1 |
112 | medline-index | 1 |
113 | mesalazine-controlled | 1 |
114 | moderately-early-treatment | 1 |
115 | monointervention | 1 |
116 | motility-ultrastructure | 1 |
117 | nc-siaa | 1 |
118 | non-peptidyl | 1 |
119 | organism-wide | 1 |
120 | organs.bpa | 1 |
121 | other.six | 1 |
122 | patholo-histological | 1 |
123 | pivotal/registration | 1 |
124 | practice-pattern | 1 |
125 | pre-1997 | 1 |
126 | pre-mentioned | 1 |
127 | remaining15 | 1 |
128 | results.four | 1 |
129 | soil-sampling | 1 |
130 | speed-change | 1 |
131 | spincaloric | 1 |
132 | sstr5-specific | 1 |
133 | study-driven | 1 |
134 | survival/toxicity | 1 |
135 | switchmrk | 1 |
136 | tested.no | 1 |
137 | trial.fifteen | 1 |
138 | trials.fifteen | 1 |
139 | ua5 | 1 |
140 | uroflowmetry/emg | 1 |
141 | valid/eligible | 1 |
142 | year-through | 1 |
1 | 4,884 | 1 |
2 | 41,175 | 1 |
3 | aerobiological | 2 |
4 | anatomo-histopathological | 1 |
5 | anthropological | 78 |
6 | anti-aml | 3 |
7 | archaeological | 44 |
8 | asian-specific | 3 |
9 | autoradiographic | 17 |
10 | bencaological | 1 |
11 | best-conducted | 1 |
12 | biodemographic | 4 |
13 | bioptical | 1 |
14 | brain-imaging | 10 |
15 | brec | 1 |
16 | carefully-designed | 2 |
17 | case-series/registry | 1 |
18 | clinico-epidemiological | 5 |
19 | comparators.two | 1 |
20 | continuous-feed | 5 |
21 | correlative | 137 |
22 | cric/h-cric | 2 |
23 | decision-analysis-based | 3 |
24 | decision-modeling | 2 |
25 | depression.the | 1 |
26 | designs-randomized | 1 |
27 | direct-tracking | 1 |
28 | ecological-genomic | 1 |
29 | entomological | 57 |
30 | epidemiologic | 1,717 |
31 | epidemiological | 3,293 |
32 | epidemiological/clinical | 3 |
33 | eppm-based | 2 |
34 | equigen | 2 |
35 | ethno-botanical | 20 |
36 | ethno-pharmacological | 8 |
37 | ethnobiological | 26 |
38 | ethnobotanic | 5 |
39 | ethnobotanical | 475 |
40 | ethnographical | 3 |
41 | ethnological | 3 |
42 | ethnomycological | 5 |
43 | ethnopharmacobotanical | 1 |
44 | ethnopharmacological | 281 |
45 | ethnozoological | 21 |
46 | ex-vivo | 72 |
47 | experimental-pharmacological | 1 |
48 | flow-microscopy | 4 |
49 | functionai | 1 |
50 | genome-analysis | 1 |
51 | gst-pulldown | 3 |
52 | health.five | 1 |
53 | histocytological | 3 |
54 | hiv/hpv | 4 |
55 | hrql.further | 1 |
56 | hypothesis-based | 4 |
57 | immuno-histological | 2 |
58 | in-vitro | 373 |
59 | in-vivo | 208 |
60 | insync-icd | 2 |
61 | iris/enest-nd/dasision | 1 |
62 | isotope-labeling | 3 |
63 | jcpds | 1 |
64 | literature-reported | 2 |
65 | longest-duration | 1 |
66 | low-coverage | 1 |
67 | mechanism/efficacy | 1 |
68 | mechanistical | 3 |
69 | medline-index | 1 |
70 | mesalazine-controlled | 1 |
71 | meta-profiling | 2 |
72 | microneurographic | 2 |
73 | moderately-early-treatment | 1 |
74 | monointervention | 1 |
75 | monophagous | 2 |
76 | motility-ultrastructure | 1 |
77 | nanoparticle-cell | 2 |
78 | nc-siaa | 1 |
79 | neuro-imaging | 10 |
80 | neuroimaging | 592 |
81 | non-asian-dominant | 5 |
82 | non-peptidyl | 1 |
83 | non-pooled | 3 |
84 | non-rodent | 3 |
85 | nonexperimental | 40 |
86 | nonindustry | 3 |
87 | organism-wide | 1 |
88 | organs.bpa | 1 |
89 | other.six | 1 |
90 | paleoparasitological | 2 |
91 | palynological | 2 |
92 | patholo-histological | 1 |
93 | patophysiological | 4 |
94 | pharmacal | 3 |
95 | pharmacoepidemiological | 36 |
96 | pharmacognostical | 6 |
97 | pharmacokinetic/pharmacodynamics | 2 |
98 | phenotype/genotype | 2 |
99 | phytopharmacological | 7 |
100 | pivotal/registration | 1 |
101 | postrotation | 2 |
102 | practice-pattern | 1 |
103 | pre-1997 | 1 |
104 | pre-clinical | 302 |
105 | pre-mentioned | 1 |
106 | preclinical | 2,405 |
107 | preclinical/clinical | 5 |
108 | preformulation | 7 |
109 | quadrat | 2 |
110 | radioecological | 2 |
111 | radioligand-binding | 4 |
112 | random-control | 2 |
113 | rct-level | 2 |
114 | remaining15 | 1 |
115 | results.four | 1 |
116 | rnaseq | 4 |
117 | rt-tmz-10.00 | 2 |
118 | sero-epidemiological | 4 |
119 | seroepidemiologic | 4 |
120 | seroepidemiological | 22 |
121 | soil-sampling | 1 |
122 | speed-change | 1 |
123 | spinal-reflex | 3 |
124 | spincaloric | 1 |
125 | sstr5-specific | 1 |
126 | study-driven | 1 |
127 | summary-level | 3 |
128 | survival/toxicity | 1 |
129 | switchmrk | 1 |
130 | tested.no | 1 |
131 | thermal-conductivity | 2 |
132 | time-of-addition | 5 |
133 | titration-to-response | 4 |
134 | toxicogenomic | 9 |
135 | transcriptome-scale | 3 |
136 | trial.fifteen | 1 |
137 | trials.fifteen | 1 |
138 | ua- | 2 |
139 | ua5 | 1 |
140 | uroflowmetry/emg | 1 |
141 | valid/eligible | 1 |
142 | year-through | 1 |
1 | ua- | 2 |
2 | rt-tmz-10.00 | 2 |
3 | 4,884 | 1 |
4 | remaining15 | 1 |
5 | 41,175 | 1 |
6 | ua5 | 1 |
7 | pre-1997 | 1 |
8 | nc-siaa | 1 |
9 | organs.bpa | 1 |
10 | brec | 1 |
11 | sstr5-specific | 1 |
12 | asian-specific | 3 |
13 | epidemiologic | 1,717 |
14 | seroepidemiologic | 4 |
15 | autoradiographic | 17 |
16 | biodemographic | 4 |
17 | microneurographic | 2 |
18 | ecological-genomic | 1 |
19 | toxicogenomic | 9 |
20 | ethnobotanic | 5 |
21 | cric/h-cric | 2 |
22 | spincaloric | 1 |
23 | insync-icd | 2 |
24 | continuous-feed | 5 |
25 | mesalazine-controlled | 1 |
26 | non-pooled | 3 |
27 | carefully-designed | 2 |
28 | pre-mentioned | 1 |
29 | eppm-based | 2 |
30 | hypothesis-based | 4 |
31 | decision-analysis-based | 3 |
32 | best-conducted | 1 |
33 | literature-reported | 2 |
34 | designs-randomized | 1 |
35 | organism-wide | 1 |
36 | low-coverage | 1 |
37 | speed-change | 1 |
38 | depression.the | 1 |
39 | transcriptome-scale | 3 |
40 | valid/eligible | 1 |
41 | phenotype/genotype | 2 |
42 | motility-ultrastructure | 1 |
43 | titration-to-response | 4 |
44 | health.five | 1 |
45 | correlative | 137 |
46 | uroflowmetry/emg | 1 |
47 | radioligand-binding | 4 |
48 | brain-imaging | 10 |
49 | neuro-imaging | 10 |
50 | neuroimaging | 592 |
51 | direct-tracking | 1 |
52 | isotope-labeling | 3 |
53 | decision-modeling | 2 |
54 | meta-profiling | 2 |
55 | soil-sampling | 1 |
56 | year-through | 1 |
57 | functionai | 1 |
58 | switchmrk | 1 |
59 | pharmacal | 3 |
60 | bencaological | 1 |
61 | experimental-pharmacological | 1 |
62 | ethno-pharmacological | 8 |
63 | ethnopharmacological | 281 |
64 | phytopharmacological | 7 |
65 | radioecological | 2 |
66 | ethnomycological | 5 |
67 | archaeological | 44 |
68 | anatomo-histopathological | 1 |
69 | ethnobiological | 26 |
70 | aerobiological | 2 |
71 | epidemiological | 3,293 |
72 | clinico-epidemiological | 5 |
73 | sero-epidemiological | 4 |
74 | pharmacoepidemiological | 36 |
75 | seroepidemiological | 22 |
76 | patophysiological | 4 |
77 | entomological | 57 |
78 | ethnological | 3 |
79 | palynological | 2 |
80 | ethnozoological | 21 |
81 | anthropological | 78 |
82 | paleoparasitological | 2 |
83 | patholo-histological | 1 |
84 | immuno-histological | 2 |
85 | histocytological | 3 |
86 | ethnographical | 3 |
87 | ethno-botanical | 20 |
88 | ethnopharmacobotanical | 1 |
89 | ethnobotanical | 475 |
90 | pre-clinical | 302 |
91 | epidemiological/clinical | 3 |
92 | preclinical/clinical | 5 |
93 | preclinical | 2,405 |
94 | bioptical | 1 |
95 | mechanistical | 3 |
96 | pharmacognostical | 6 |
97 | nonexperimental | 40 |
98 | rct-level | 2 |
99 | summary-level | 3 |
100 | nanoparticle-cell | 2 |
101 | anti-aml | 3 |
102 | random-control | 2 |
103 | non-peptidyl | 1 |
104 | trial.fifteen | 1 |
105 | trials.fifteen | 1 |
106 | equigen | 2 |
107 | study-driven | 1 |
108 | iris/enest-nd/dasision | 1 |
109 | preformulation | 7 |
110 | pivotal/registration | 1 |
111 | longest-duration | 1 |
112 | postrotation | 2 |
113 | time-of-addition | 5 |
114 | monointervention | 1 |
115 | practice-pattern | 1 |
116 | gst-pulldown | 3 |
117 | tested.no | 1 |
118 | in-vitro | 373 |
119 | in-vivo | 208 |
120 | ex-vivo | 72 |
121 | comparators.two | 1 |
122 | rnaseq | 4 |
123 | hrql.further | 1 |
124 | results.four | 1 |
125 | pharmacokinetic/pharmacodynamics | 2 |
126 | jcpds | 1 |
127 | genome-analysis | 1 |
128 | monophagous | 2 |
129 | quadrat | 2 |
130 | non-asian-dominant | 5 |
131 | non-rodent | 3 |
132 | moderately-early-treatment | 1 |
133 | hiv/hpv | 4 |
134 | medline-index | 1 |
135 | spinal-reflex | 3 |
136 | other.six | 1 |
137 | mechanism/efficacy | 1 |
138 | flow-microscopy | 4 |
139 | case-series/registry | 1 |
140 | nonindustry | 3 |
141 | survival/toxicity | 1 |
142 | thermal-conductivity | 2 |